Indications and uses
This product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product.
This product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product.
Usual adult dose is 1 to 2 tablets daily, or as directed by a physician.
Rx Only Dietary Supplement
This product is a prescription dietary supplement for oral administration, specifically formulated for the dietary management of patients with unique nutritional needs who require increased levels of one or more of the ingredients in this product. Each tan colored caplet-shaped tablet is debossed with “203” on one side and plain on the other.
Each tablet of NicaprinTM contains:
| Niacin (nicotinamide) | 250 mg |
| Folic Acid | 500 mcg |
| Vitamin B6 (pyridoxine HCl) | 4.5 mg |
| Copper (cupric oxide) | 1.4 mg |
| Zinc (zinc oxide) | 9 mg |
| Soliprin (scutellaria baicalensis (root) & acacia catechu (heartwood)) | 125 mg |
Iron oxide, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium bicarbonate, starch, silica, talc, and titanium dioxide.
This product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product.
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
This product should be administered with caution in patients with a history of liver disease, jaundice or diabetes mellitus. While prescribing this product for pregnant women, nursing mothers, or for women prior to conception, their medical condition and use of other drugs, herbs and/or supplements should be considered. Folic acid above 1 mg daily may obscure pernicious anemia in that hematologic remission may occur while neurological manifestations remain progressive. Abnormal liver functions tests have been reported in persons taking daily doses of 500 mg or more of niacinamide.
KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
This product is not indicated for use as a prenatal/postnatal multivitamin for lactating and nonlactating mothers. Physicians and medical practitioners should administer this product with caution to patients who are pregnant, lactating and/or taking medication.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You should call your doctor for medical advice about side effects. To report a serious adverse event, call 1-855-899-4237.
Usual adult dose is 1 to 2 tablets daily, or as directed by a physician.
This product is supplied in the following size(s):
60 count bottles, NDC 57893-203-60
Store between 15°C and 30°C (between 59°F and 86°F). Tamper evident by foil seal under cap.
Manufactured for:
Artesa Labs, LLC
137585 Research Blvd.
Suite 125
Austin, TX 78750
v1 Rev. 05/16 826146
NDC 57893-203-60
Rx Only
NICAPRINTM
Dietary Supplement
60 Tablets
Artesa Labs
| Class | Version | Type | Effective |
|---|---|---|---|
| NIACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57893-203-60 | NICAPRIN | 60 in 1 BOTTLE | TABLET | 60 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57893-203-60 | EA - Each | 57893-203 | 6332b530-a6c8-4f3b-90d8-036a5ed066c1 | 1 | 2016-11-08 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57893-203 | 57893-203-60 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Niacin | NIACIN | Golden State Medical Supply, Inc. | 8eff9205-84ac-e69d-e053-2995a90aad4b | 2026-04-15 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | AvPAK | dd60fe81-3d54-4a29-9502-601be89c575e | 2026-02-25 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | QUAGEN PHARMACEUTICALS LLC | 249e27ac-e1e7-42dc-84f6-cd32fd1d9dee | 2025-12-25 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Redmont Pharmaceuticals, LLC | f51f7e6d-b132-48d8-8bb1-54203472f0d8 | 2025-12-17 | Warnings, Adverse reactions | NIACIN |
| NIACIN | NIACIN | Chartwell RX, LLC | 568c3a99-b6e8-48b4-bb68-867bbcefa027 | 2025-12-08 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Lannett Company, Inc. | d7b66e13-00ed-48a9-a54a-8e474cc31d54 | 2025-11-10 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Amneal Pharmaceuticals LLC | 7250313b-b2ef-4736-bd25-2f29c2ac0eb9 | 2025-10-03 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Macleods Pharmaceuticals Limited | 52ad4a6a-81cc-4b03-b8b1-3bd9a1d4064e | 2025-01-10 | Warnings, Adverse reactions | NIACIN |
| NIACIN | NIACIN | Sun Pharmaceutical Industries, Inc. | 8e290f96-e8c6-47fd-863f-1c9480f28d9b | 2023-11-24 | Warnings, Adverse reactions | NIACIN |
| NIACIN | NIACIN | Lupin Pharmaceuticals, Inc. | 92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9 | 2023-10-06 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Aurobindo Pharma Limited | 43233a21-3f90-4c69-bbeb-f50d5f2d35ae | 2023-02-14 | Warnings, Adverse reactions | NIACIN |
| Niacor | NIACIN | Avondale Pharmaceuticals, LLC | bf287412-160b-403f-8eb4-57f29a475902 | 2021-12-23 | Warnings, Adverse reactions | NIACIN |
| Niacin | NIACIN | Emerald Therapeutics, LLC | 5fceeb58-e54d-43c1-8abb-33feea69d663 | 2021-04-07 | Warnings, Adverse reactions | NIACIN |
Adverse event summaries are temporarily unavailable. Other product information remains available.